Skip to content
Search for:
The Society
Board of Directors
Scientific Advisory Council
Society Calendar
Contact
Science News
Recent Articles
President’s Pick and Perspective
Rare Disease Task Force
Rare Disease Briefing Document
Journal
Resources
Awards & Grants
Lifetime Achievement Award
Young Investigator Award
Dr. Alan M. Gewirtz Memorial Scholarship
Paper of the Year
Travel Grants
Travel Grant Recipients
Poster Awards
OTS Poster Award Winners
OTS Local Delivery Application
OTS Local Delivery – Program Overview
OTS Local Delivery Program – FAQ
Recommended Resources
Upcoming Events
Recent Articles
Archive
Video Gallery
Webinars
Job Postings
Employer Profiles
Employer Registration / Login
Meetings
2022 Annual Meeting
2021 Annual Meeting
2020 Annual Meeting
Past Annual Meetings
Conference Calendar
Membership
Become A Member
Featured Members
Current Status of Messenger RNA Delivery Systems
AUTHOR
OTS
DATE
June 30, 2018
CATEGORIES
Delivery
,
Reviews
SHARE
Post Views:
266
Stanton MG.
Nucleic Acid Ther. 2018 Jun;28(3):158-165.
PubMed
Previous
Next
Related articles
How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands
How to Develop and Prove High-Efficiency Selection of Ligands from Oligonucleotide Libraries: A Universal Framework for Aptamers and DNA-Encoded Small-Molecule Ligands
April 23rd, 2021
|
0 Comments
Recent progress in non-native nucleic acid modifications
Recent progress in non-native nucleic acid modifications
April 23rd, 2021
|
0 Comments
Flash Synthesis of Spherical Nucleic Acids with Record DNA Density
Flash Synthesis of Spherical Nucleic Acids with Record DNA Density
April 23rd, 2021
|
0 Comments
Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
April 23rd, 2021
|
0 Comments
Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy
Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy
April 23rd, 2021
|
0 Comments
Non-specific interactions of antibody-oligonucleotide conjugates with living cells
Non-specific interactions of antibody-oligonucleotide conjugates with living cells
April 23rd, 2021
|
0 Comments
Page load link
Go to Top
